π”»π•’π•Ÿπ•šπ•€π•™/π•Šπ•¨π•–π••π•šπ•€π•™ π•Šπ•₯𝕦𝕕π•ͺ 𝔸𝕑𝕑𝕖𝕒𝕣𝕀 π•₯𝕠 π•π•’π•π•šπ••π•’π•₯𝕖 ℙ𝕠π•₯π•–π•Ÿπ•₯π•šπ•’π•π•π•ͺ 𝔹𝕒𝕕 𝔹𝕒π•₯𝕔𝕙𝕖𝕀 𝕠𝕗 β„™π•—π•šπ•«π•–π•£-π”Ήπ•šπ• β„•π•‹π•–π•”π•™ π•žβ„β„•π”Έ π•π•’π•”π•”π•šπ•Ÿπ•– (π”Ήβ„•π•‹πŸ™πŸžπŸšπ•“πŸš), π•ƒπ•šπ•Ÿπ•œπ•–π•• π•₯𝕠 π•Šπ”Έπ”Όπ•€

π”»π•’π•Ÿπ•šπ•€π•™/π•Šπ•¨π•–π••π•šπ•€π•™ π•Šπ•₯𝕦𝕕π•ͺ 𝔸𝕑𝕑𝕖𝕒𝕣𝕀 π•₯𝕠 π•π•’π•π•šπ••π•’π•₯𝕖 ℙ𝕠π•₯π•–π•Ÿπ•₯π•šπ•’π•π•π•ͺ 𝔹𝕒𝕕 𝔹𝕒π•₯𝕔𝕙𝕖𝕀 𝕠𝕗 β„™π•—π•šπ•«π•–π•£-π”Ήπ•šπ• β„•π•‹π•–π•”π•™ π•žβ„β„•π”Έ π•π•’π•”π•”π•šπ•Ÿπ•– (π”Ήβ„•π•‹πŸ™πŸžπŸšπ•“πŸš), π•ƒπ•šπ•Ÿπ•œπ•–π•• π•₯𝕠 π•Šπ”Έπ”Όπ•€

A wide variation in the risk of side effects after COVID-19 vaccination was found from another previous study in Denmark. For example, some of the people who received Pfizer/BioNTech’s mRNA-based COVID-19 (BNT162b2) vaccine especially earlier on had a significantly higher risk of reported side effects than others.

What’s behind such an observation? Enter the study led by physician-scientist and author Vibeke Manniche, MD, PhD, and colleagues including prominent University of Copenhagen cardiologist and professor Peter Riis Hansen, MD DMSc PhD. The four collaborators sought to confirm previous findings (Schmeling et al., 2023) in an independent data set by analyzing publicly available records of suspected adverse events related to BNT162b2/Comirnaty from the Swedish Medical Products Agency (57,000 records spanning 3 years of reports).

𝕋𝕙𝕖 π•Šπ•₯𝕦𝕕π•ͺ

A nationwide Danish study found an unexpected batch-dependent safety signal for the Pfizer-BioNTech (BNT162b2) mRNA COVID-19 vaccine, however, the generalizability of such a finding was unknown.

Hence this study led by Vibeke Manniche, MD, PhD, and colleagues including Peter Riis Hansen, University of Copenhagen’s Department of Clinical Medicine comparing batch-dependent rates of suspected adverse events (SAEs) reported to national authorities in Denmark and Sweden. 

Analyzing SAEs and vaccine batch data from national authorities in Denmark and Sweden, the investigators performed an analysis of heterogeneity in the relationship between numbers of vaccine doses and SAEs per batch, as well as comparing SAE rates and severities for batches that were shared between the two countries. 

Dr. Vibeke Manniche went on the record, β€œWith this new study, we have been able to confirm a major safety issue with Pfizer’s COVID-19 vaccine. The Swedish data shows that this was not just a phenomenon in Denmark, as our earlier study has shown, but likely to be a widespread problem.”

ℙ𝕣𝕠𝕛𝕖𝕔π•₯ π•π•–π•£π•šπ•₯𝕒𝕀

Read between the lines and what he is saying, and stating…

𝔾-𝕓𝕫

Here are the released Pfizer Documents with the thousands of Side Effects that they desperately tried to have Sealed and Hidden from YOU, for 75 years.

𝔹𝕠𝕓𝕓π•ͺ 𝔹𝕣π•ͺπ•’π•Ÿπ•₯

We can not believe that this guy below is still the Ceo of Pfizer….

π•‚π•£π• π•€π•”π•™π•–π•”π•œ

Source